Abstract
Every successful pregnancy requires proper embryo implantation. Low implantation rate is a major problem during infertility treatments using assisted reproductive technologies1. Here we report a newly discovered molecular influence on implantation through the lysophosphatidic acid (LPA) receptor LPA3 (refs 2–4). Targeted deletion of LPA3 in mice resulted in significantly reduced litter size, which could be attributed to delayed implantation and altered embryo spacing. These two events led to delayed embryonic development, hypertrophic placentas shared by multiple embryos and embryonic death. An enzyme demonstrated to influence implantation, cyclooxygenase 2 (COX2) (ref. 5), was downregulated in LPA3-deficient uteri during pre-implantation. Downregulation of COX2 led to reduced levels of prostaglandins E2 and I2 (PGE2 and PGI2), which are critical for implantation1. Exogenous administration of PGE2 or carbaprostacyclin (a stable analogue of PGI2) into LPA3-deficient female mice rescued delayed implantation but did not rescue defects in embryo spacing. These data identify LPA3 receptor-mediated signalling as having an influence on implantation, and further indicate linkage between LPA signalling and prostaglandin biosynthesis.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
£199.00 per year
only £3.90 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Dey, S. K. et al. Molecular cues to implantation. Endocr. Rev. 25, 341–373 (2004)
Ishii, I., Fukushima, N., Ye, X. & Chun, J. Lysophospholipid receptors: signaling and biology. Annu. Rev. Biochem. 73, 321–354 (2004)
Bandoh, K. et al. Molecular cloning and characterization of a novel human G-protein-coupled receptor, EDG7, for lysophosphatidic acid. J. Biol. Chem. 274, 27776–27785 (1999)
Contos, J. J. & Chun, J. The mouse lp(A3)/Edg7 lysophosphatidic acid receptor gene: genomic structure, chromosomal localization, and expression pattern. Gene 267, 243–253 (2001)
Lim, H. et al. Multiple female reproductive failures in cyclooxygenase 2-deficient mice. Cell 91, 197–208 (1997)
Cleary-Goldman, J. & D'Alton, M. Management of single fetal demise in a multiple gestation. Obstet. Gynecol. Surv. 59, 285–298 (2004)
Umstad, M. P. & Gronow, M. J. Multiple pregnancy: a modern epidemic? Med. J. Aust. 178, 613–615 (2003)
Daniel, Y. et al. Analysis of 104 twin pregnancies conceived with assisted reproductive technologies and 193 spontaneously conceived twin pregnancies. Fertil. Steril. 74, 683–689 (2000)
Wilcox, A. J., Baird, D. D. & Weinberg, C. R. Time of implantation of the conceptus and loss of pregnancy. N. Engl. J. Med. 340, 1796–1799 (1999)
Tokumura, A., Fukuzawa, K., Yamada, S. & Tsukatani, H. Stimulatory effect of lysophosphatidic acids on uterine smooth muscles of non-pregnant rats. Arch. Int. Pharmacodyn. Ther. 245, 74–83 (1980)
Contos, J. J., Fukushima, N., Weiner, J. A., Kaushal, D. & Chun, J. Requirement for the lpA1 lysophosphatidic acid receptor gene in normal suckling behavior. Proc. Natl Acad. Sci. USA 97, 13384–13389 (2000)
Contos, J. J. et al. Characterization of lpa2 (Edg4) and lpa1/lpa2 (Edg2/Edg4) lysophosphatidic acid receptor knockout mice: signaling deficits without obvious phenotypic abnormality attributable to lpa2 . Mol. Cell. Biol. 22, 6921–6929 (2002)
Kingsbury, M. A., Rehen, S. K., Contos, J. J., Higgins, C. M. & Chun, J. Non-proliferative effects of lysophosphatidic acid enhance cortical growth and folding. Nature Neurosci. 6, 1292–1299 (2003)
Inoue, M. et al. Initiation of neuropathic pain requires lysophosphatidic acid receptor signaling. Nature Med. 10, 712–718 (2004)
Noguchi, K., Ishii, S. & Shimizu, T. Identification of p2y9/GPR23 as a novel G protein-coupled receptor for lysophosphatidic acid, structurally distant from the Edg family. J. Biol. Chem. 278, 25600–25606 (2003)
Paria, B. C., Huet-Hudson, Y. M. & Dey, S. K. Blastocyst's state of activity determines the “window” of implantation in the receptive mouse uterus. Proc. Natl Acad. Sci. USA 90, 10159–10162 (1993)
Kennedy, T. G. Evidence for a role for prostaglandins in the initiation of blastocyst implantation in the rat. Biol. Reprod. 16, 286–291 (1977)
Kinoshita, K. et al. Involvement of prostaglandins in implantation in the pregnant mouse. Adv. Prostaglandin Thromboxane Leukot. Res. 15, 605–607 (1985)
Song, H. et al. Cytosolic phospholipase A2α is crucial for ‘on-time’ embryo implantation that directs subsequent development. Development 129, 2879–2889 (2002)
Frenkian, M., Segond, N., Pidoux, E., Cohen, R. & Jullienne, A. Indomethacin, a COX inhibitor, enhances 15-PGDH and decreases human tumoral C cells proliferation. Prostaglandins 65, 11–20 (2001)
Reese, J., Brown, N., Paria, B. C., Morrow, J. & Dey, S. K. COX-2 compensation in the uterus of COX-1 deficient mice during the pre-implantation period. Mol. Cell. Endocrinol. 150, 23–31 (1999)
Sibilia, M. & Wagner, E. F. Strain-dependent epithelial defects in mice lacking the EGF receptor. Science 269, 234–238 (1995)
Wang, H. et al. Rescue of female infertility from the loss of cyclooxygenase-2 by compensatory up-regulation of cyclooxygenase-1 is a function of genetic makeup. J. Biol. Chem. 279, 10649–10658 (2004)
Lim, H. et al. Cyclo-oxygenase-2-derived prostacyclin mediates embryo implantation in the mouse via PPARδ. Genes Dev. 13, 1561–1574 (1999)
Yang, Z. M. et al. Potential sites of prostaglandin actions in the periimplantation mouse uterus: differential expression and regulation of prostaglandin receptor genes. Biol. Reprod. 56, 368–379 (1997)
Paria, B. C., Song, H. & Dey, S. K. Implantation: molecular basis of embryo-uterine dialogue. Int. J. Dev. Biol. 45, 597–605 (2001)
Gabardi, S. & Cerio, J. Future immunosuppressive agents in solid-organ transplantation. Prog. Transplant. 14, 148–156 (2004)
Ishii, I. et al. Marked perinatal lethality and cellular signaling deficits in mice null for the two sphingosine 1-phosphate (S1P) receptors, S1P2/LPB2/EDG-5 and S1P3/LPB3/EDG-3. J. Biol. Chem. 277, 25152–25159 (2002)
Hama, K. et al. Lysophosphatidic acid and autotaxin stimulate cell motility of neoplastic and non-neoplastic cells through LPA1. J. Biol. Chem. 279, 17634–17639 (2004)
Ishii, I. et al. Selective loss of sphingosine 1-phosphate signaling with no obvious phenotypic abnormality in mice lacking its G protein-coupled receptor, LPB3/EDG-3. J. Biol. Chem. 276, 33697–33704 (2001)
Acknowledgements
We thank F. Liu, S. Kupriyanov, R. Rivera, D. Herr, E. Nilsson, M. Murakami, Y. Kita, B. C. Paria, C. Akita, S. Carlson and Q. Chen for technical assistance and suggestions. This work was supported by grants from the National Institute of Mental Health to J.C. and J.J.A.C., the National Institute of Health to M.K.S, Swiss National Science Foundation to B.A., and Program for Promotion of Fundamental Studies in Health Sciences of the Pharmaceuticals and Medical Devices Agency (PMDA) and grants-in-aid from the Ministry of Education, Science, Culture and Sports for the 21st Century Center of Excellence Program, Japan, to H.S., J.A and H.A.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare that they have no competing financial interests.
Supplementary information
Supplementary Table S1
Inheritance of mutated LPA3 allele. (DOC 24 kb)
Supplementary Table S2
Mating study. (DOC 21 kb)
Supplementary Figure S1
Targeted disruption of LPA3. (JPG 155 kb)
Supplementary Figure S2
Verification of loss of LPA3 function after targeted deletion of LPA3. (JPG 713 kb)
Supplementary Figure S3
Expression of LPA3 mRNA in WT uterus. (JPG 131 kb)
Supplementary Figure S4
Identification/characterization of defects in LPA3-deficient female reproduction. (JPG 110 kb)
Supplementary Figure S5
Comparison of placentas from E18.5 control and LPA3-deficient females. (JPG 100 kb)
Supplementary Figure S6
Confirmation of maternal defects for implantation phenotypes. (JPG 651 kb)
Supplementary Figure S7
Expression of LIF, Hoxa-10, and cPLA2α in E3.5 uteri. (JPG 96 kb)
Supplementary Figure S8
Additional information about potential dominant negative effect and genetic background. (JPG 657 kb)
Supplementary Figure Legends
Including figure legends for all 8 Supplementary Figures. (DOC 35 kb)
Supplementary Methods
The Supplementary Methods used to obtain data in Supplementary Figures and additional references. (DOC 42 kb)
Rights and permissions
About this article
Cite this article
Ye, X., Hama, K., Contos, J. et al. LPA3-mediated lysophosphatidic acid signalling in embryo implantation and spacing. Nature 435, 104–108 (2005). https://doi.org/10.1038/nature03505
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/nature03505
This article is cited by
-
Lysophosphatidic acid is associated with oocyte maturation by enhancing autophagy via PI3K-AKT-mTOR signaling pathway in granulosa cells
Journal of Ovarian Research (2023)
-
Role of functional fatty acids in modulation of reproductive potential in livestock
Journal of Animal Science and Biotechnology (2023)
-
Progress on the Role of Estrogen and Progesterone Signaling in Mouse Embryo Implantation and Decidualization
Reproductive Sciences (2023)
-
Intrauterine botulinum toxin A administration promotes endometrial regeneration mediated by IGFBP3-dependent OPN proteolytic cleavage in thin endometrium
Cellular and Molecular Life Sciences (2023)
-
The emerging importance of METTL5-mediated ribosomal RNA methylation
Experimental & Molecular Medicine (2022)